Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medexus Pharmaceuticals Inc T.MDP

Alternate Symbol(s):  MEDXF

Healthcare
Medexus Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company with a North American commercial platform. The Company has a portfolio of rare disease treatment solutions. Its focus is on the therapeutic areas of oncology, hematology, rheumatology, autoimmune diseases, allergy, and dermatology. It operates through two segments: Medexus Pharma Canada and Medexus Pharma USA. Its... see more

TSX:MDP - Post Discussion

Medexus Pharmaceuticals Inc > The drug Gleolan ...
View:
Post by Rockafellow on Mar 24, 2021 7:17am

The drug Gleolan ...

... A product of MDP was successfully used in Halifax to help surgeons remove a brain timour. It costs $3000 for one dose but helps identify the tumour from good tissue for a better recovery. It is highly recommended.
Comment by christophwaltz on Mar 24, 2021 10:33am
They stated in that article (https://www.cbc.ca/news/canada/nova-scotia/brain-surgery-halifax-advance-fighting-cancer-1.5920258) that there were 25-30 such surgeries done yearly "by the surgical group in Nova Scotia". I wonder if that's the entire province's surgies. Populatin of Nova Scota is just shy of 1M at 970,000. Extraoplate that to all of Canada (37.5M) and that's ...more  
Comment by Rockafellow on Mar 25, 2021 12:41pm
UR calculations r overdone I think... They only got approval in Canada for Gleolan last month so  Halifax was probably the first use of the product... ... Their sales on other drugs for last yr was about 110  $mil or 5$/sh.... ... ... The proposed sales this yr for a new drug treosultan is expected to be about $100 mil US so add another $5 bucks on the share price.... .... ... This doesn ...more  
Medexus Pharmaceuticals Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities